H.R. 5926 · 115th Congress
Naloxone Guidelines Act of 2018
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
KeatingSponsor1 cosponsor · 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).
What it does: CRS summary · Introduced in House · May 23, 2018
Naloxone Guidelines Act of 2018
This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).
The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including:
- co-prescription with an opioid;
- safe dosages;
- prescription for non-patients; and
- standing orders (i.e., orders that allow dispensing without a prescription).
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Naloxone Guidelines Act of 2018
Latest action (May 23, 2018): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: May 23, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.